GIM
IBB icon

Greystone Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Greystone Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$4.09M Sell
42,401
-591
-1% -$62.7K 2.09% 21
2018
Q3 		$5.24M Hold
42,992
– – 2.26% 19
2018
Q2 		$4.72M Sell
42,992
-205
-0.5% -$21.9K 2.17% 20
2018
Q1 		$4.61M Sell
43,197
-270
-0.6% -$29.9K 2.14% 21
2017
Q4 		$4.64M Sell
43,467
-15
-0% -$1.6K 2.1% 19
2017
Q3 		$4.83M Sell
43,482
-720
-2% -$77K 2.33% 19
2017
Q2 		$4.57M Sell
44,202
-20,160
-31% -$1.99M 2.22% 20
2017
Q1 		$6.29M Sell
64,362
-420
-0.6% -$40.2K 3.05% 14
2016
Q4 		$5.73M Sell
64,782
-8,400
-11% -$765K 2.98% 13
2016
Q3 		$7.06M Sell
73,182
-10,380
-12% -$987K 3.58% 10
2016
Q2 		$7.17M Buy
+83,562
New +$7.5M 3.24% 13

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Greystone Investment Management's IBB Position: Q4 2018 in Review

Greystone Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 1.4% in Q4 2018, selling an estimated $62.7K and leaving 42,401 shares worth $4.09M. The position accounts for 2.09% of the portfolio, ranked #21.

Greystone Investment Management first reported a position in IBB in Q2 2016 and has held it in 11 quarters since. The position peaked at $7.17M in Q2 2016. 649 funds tracked by Wall St. Rank hold IBB as of Q4 2018.

  • Greystone Investment Management held 42,401 shares of iShares Biotechnology ETF worth $4.09M as of Q4 2018.
  • Greystone Investment Management sold 591 iShares Biotechnology ETF shares in Q4 2018, an estimated $62.7K.
  • iShares Biotechnology ETF made up 2.09% of Greystone Investment Management's portfolio in Q4 2018, its #21 holding.
  • Greystone Investment Management first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 11 quarters since.
  • Greystone Investment Management's iShares Biotechnology ETF position peaked at $7.17M in Q2 2016.
  • 649 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2018.

Based on Greystone Investment Management's 13F filing for Q4 2018, filed 14 Jan 2019.